Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc.

3.06
EUR
+0.00
(+0.13%)
-0.52EPS
703.45MMarket Cap
Feb 25Next Earn

Aclaris Therapeutics, Inc. Documents

Q2 FY2025 · Quarterly report

August 7, 2025 · 59 pages

Read Aclaris Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this quarterly report
Create a free account to start reading

Full documents are included with Professional

Q2 FY2025 documents